45
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Physiological and Clinical Aspects of Vitamin A and Its Metabolites

&
Pages 185-215 | Published online: 27 Sep 2008

References

  • Aykroyd W R. Beriberi and other food deficiency diseases in Newfoundland and Labrador. J Hyg 1930; 30: 357–86
  • McCollum E V., Davis M. The necessity of certain lipins in the diet during growth. J Biol Chem 1913; 15: 167–75
  • Osborne T B., Mendel L B. Influence of butterfat on growth. J Biol Chem 1913; 16: 423–37
  • Hume E M. The effect of radiation with the mercury vapour quartz lamp on the growth of rats on a diet deficient in vitamin A. Lancet 1922; ii: 1318–21
  • Goldblatt H, Zilva S S. The relation between the growth promoting and anti-rachitic functions of certain substances. Lancet 1923; ii: 647–49
  • Capper N S. The alleged contamination of carotene by vitamin A. The transformation of carotene into vitamin A as shown by the absorption spectrum of rat liver oils. Biochem J 1930; 24: 453–5
  • Moore T. The absence of the liver oil vitamin A from carotene. The conversion of carotene to vit A in vivo. Biochem J 1930; 24: 692–702
  • Isler O. Uber die Ester und Ather des synthetischen Vitamins A. Helv Chi Acta 1949; 32: 489–505
  • Karrer P, Euster C H. Zur Kenntnis des Vitamins A aus Fischtranen. Helv Chi Acta 1931; 14: 1036–1431
  • Karrer P. Synthese des Dehydrovitamins A. Helv Chi Acta 1933; 16: 557–61
  • Farrar K R., Hamlet J C., Henbest H B., et al. A polyene series. I. Anhydrovitamin A2. J Chem Soc 1952; 2763–5
  • Henbest H B., Jones E RH, Owen T C. Elucidation of the structure of vitamin A2 by photosynthesis. Chem and Ind 1951; 49–50
  • Marcus R, Coulson A M. Fat soluble vitamins. The pharmacological basis of therapeutics, Gilman A. Goodman, T W. Rail, A S. Nies, et al. Pergamon Press, New York 1990
  • Goodman D S., Blaner W S. Biosynthesis, absorption and hepatic metabolism of retinol. The retinoids, M B. Spom, A B. Roberts, D S. Goodman. Academic Press, Orlando 1984; Vol 2: 1–39
  • Goodman D S., Huang H S. Biosynthesis of vitamin A with rat intestinal enzymes. Science 1965; 149: 879–80
  • Gray E L., Morgareidge K, Cawley J D. Intestinal absorption of vitamin A in normal rat. J Nutr 1940; 20: 67–74
  • Lombardo D, Fauvel J, Guy O. Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta 1980; 611(1)136–46
  • Hollander D. Intestinal absorption of vitamins A, E, D, and K. J Lab Clin Med 1981; 97(4)449–62
  • Hollander D, Muralidhara K S. Vitamin Al intestinal absorption in vivo: influence of luminal factors on transport. Am J Physiol 1977; 232(5)E471–7
  • Hollander D, Ruble P E., Jr. Beta-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport. Am J Physiol 1978; 235(6)E686–91
  • Olson J A., Hayaishi D. The enzymatic cleavage of beta-carotene into vitamin A by soluble enzymes of rat liver and intestine. Proc Natl Acad Sci USA, 65(5)1364–70, 165
  • Lakshmanan M R., Chansang H, Olson J A. Purification and properties of carotene 15,15′-dioxygenase of rabbit intestine. J Lipid Res 1972; 13(4)477–82
  • Fidge N H., Goodman D S. The enzymatic reduction of retinal to retinol in rat intestine. J Biol Chem 1968; 243(16)4372–9
  • Goodman D S., Blomstrand R, Werner B, et al. The intestinal absorption and metabolism of vitamin A and beta-carotene in man. J Clin Invest 1966; 45(10)1615–23
  • Blomstrand R, Werner B. Studies on the intestinal absorption of radioactive beta-carotene and vitamin A in man. Conversion of beta-carotene into vitamin A. Scand J Clin Lab Invest 1967; 19(4)339–45
  • Crain F D., Lotspeich F J., Krause R F. Biosynthesis of retinoic acid by intestinal enzymes of the rat. J Lipid Res 1967; 8(3)249–54
  • Chytil F. Retinoic acid: biochemistry and metabolism. J Am Acad Dermatol 1986; 15: 741–7
  • Friedman H I., Nylund B. Intestinal fat digestion, absorption and transport. A review. Am J Clin Nutr 1980; 33(5)1108–39
  • Jackson R I., Morrisett J D., Gotto A M., Jr. Lipoprotein structure and metabolism. Physiol Rev 1976; 56(2)259–316
  • Green P H., Glickman R M. Intestinal lipoprotein metabolism. J Lipid Res 1981; 22(8)1153–73
  • Sherrill B C., Dietschy J M. Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver. J Biol Chem 1978; 253(6)1859–67
  • Hui D Y., Innerarity T L., Mahley R W. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J Biol Chem 1981; 256(11)5646–55
  • Blomhoff R, Green M, Berg T, et al. Transport and storage of vitamin A. Science 1990; 250: 399–404
  • Olson J A., Gunning D. The storage form of vitamin A in rat liver cells. J Nutr 1983; 113(11)2184–91
  • Futterman S, Andrews J S. Metabolism of the retina. IV. The composition of vitamin A ester synthesized by the retina. J Biol Chem 1964; 239: 81–4
  • Wake K. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int Rev Cytol 1980; 66: 303–53
  • McLaren D S. The luxus vitamins-A and B12. Am J Clin Nutr 1981; 34(8)1611–6
  • Blomhoff R, Helgerud P, Rasmussen M, et al. In vivo uptake of chylomicron [3H]retinyl ester by rat liver: evidence for retinol transfer from parenchymal to nonparenchymal cells. Proc Natl Acad Sci USA 1982; 79(23)7326–30
  • Harrison E H., Smith J E., Goodman D S. Unusual properties of retinyl palmitate hydrolase activity in rat liver. J Lipid Res 1979; 20(6)753–9
  • Blaner W S., Smith J E., Goodman D S. Partial purification and characterization of rat liver retinyl palmitate hydrolase. Fed Proc Fed Am Soc Exp Biol 1981; 40: 1584, (Abstr.)
  • Fidge N H., Shiratori T, Ganguly J, et al. Pathways of absorption of retinal and retinoic acid in the rat. J Lipid Res 1968; 9(1)103–9
  • Napoli J L., Pramanik B C., Williams J B., et al. Quantification of retinoic acid by gas-liquid chromatography-mass spectrometry: total versus all-trans-retinoic acid in human plasma. J Lipid Res 1985; 26: 387
  • De Leenheer A P., Lambert W E., Claeys I. all-trans-Retinoic acid: measurement of reference values in human serum by high performance liquid chromatography. J Lipid Res 1982; 23: 1362
  • Barua A B., Olson J A. Retinoyl beta-glucuronide: an endogenous compound of human blood. Am J Clin Nutr 1986; 43: 481
  • Lee M O., Dockham P, Sladek N. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. Pharmacologist 1990; 32: 156, (Abstr)
  • Lee M, Manthey C, Sladek N. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. FASEB J 1990; 4: A659, (Abstr)
  • Frolik C, Roberts A, Tavela T, et al. Isolation and identification of 4-hydroxy- and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 1979; 18: 2092–7
  • Frolik C, Roller P, Roberts A, et al. In vitro and in vivo metabolism of all-trans and 13-cis retinoic acid in hamsters. J Biol Chem 1980; 255: 8057–62
  • Roberts A, Nichols M, Newton D, et al. In vitro metabolism of retinoic acid in hamster intestine and liver. J Biol Chem 1979; 245: 6296–6302
  • Roberts A, Lamb L, Sporn M. Metabolism of all-trans-retinoic acid in hamster liver microsomes. Oxidation of 4-hydroxy- to 4-keto-retinoic acid. Arch Biochem Biophys 1980; 199: 374–83
  • Leo M, Iida S, Leiber C. Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch Biochem Biophys 1984; 234: 305–12
  • Meyskens F, Goodman G, Alberts D. 13-cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. Crit Rev Oncol Hematol 1987; 3: 75–101
  • Orfanos C, Ehlert R, Gollnick H. The retinoids: a review of their clinical pharmacology and therapeutic use. Drugs 1987; 34: 459–503
  • Lasnitzki I. Reversal of methylcholanthrene-induced changed in mouse prostates in vitro by retinoic acid and its analogues. Br J Cancer 1976; 34: 239–48
  • Mahrle G. Retinoids in oncology. Curr Prob Derm 1985; 13: 128–63
  • Chatterjee M, Banerjee M R. JV-Nitrosodiethylamine-induced nodule-like alveolar lesion and its prevention by a retinoid in BALB/C mouse mammary glands in the whole organ in culture. Carcinogenesis 1982; 3: 801–4
  • Mettlin C, Saxon G, Swanson M. Vitamin A and lung cancer. J Natl Cancer Inst 1979; 62: 1435–8
  • Hirayama T. Diet and cancer. Nutr Cancer 1979; 1: 67–81
  • Lippman S M., Meyskens F L., Jr. Retinoids for the prevention of cancer. Nutrition and cancer prevention investigating the role of micronutrients, T E. Moon, M S. Micozzi. Marcel Dekker. 1989; 243–71
  • Rask L, Anundi H, Blohme J, et al. Structural and functional studies of vitamin-A binding proteins. Ann NY Acad Sci 1981; 359: 79–90
  • Raz A, Shiratori T, Goodman D S. Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J Biol Chem 1970; 245(8)1903–12
  • Peterson P A. Characteristics of a vitamin A-transporting protein complex occurring in human serum. J Biol Chem 1971a; 246(1)34–43
  • Kanai M, Raz A, Goodman D S. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968; 47(9)2025–44
  • Goodman S G. Plasma retinol-binding protein. The retinoids, M B. Sporn, A B. Roberts, D S. Goodman. Academic Press. 1984; Vol 2: 41–88
  • Peterson P A. Studies on the interaction between prealbumin, retinol-binding protein and vitamin A. J Biol Chem 1971b; 246(1)44–9
  • van Jaarsveld P P., Edelhoch H, Goodman D S., et al. The interaction of human plasma retinolbinding with prealbumin. J Biol Chem 1973a; 248: 4698–705
  • Ferguson R N., Edelhoch H, Saroff H A., et al. Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labelled 8-anilino-l-naphthalenesulfonic acid. Biochemistry 1975; 14(2)282–9
  • Blake C C., Swan I D., Rerat C, et al. An X-ray study of the subunit structure of prealbumin. J MolBiol 1971; 61(1)217–24
  • Kanda Y, Goodman D S., Canfield R E., et al. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249(21)6796–805
  • Soprano D R., Pickett C B., Smith J E., et al. Biosynthesis of plasma retinol-binding protein in liver as a larger molecular weight precursor. J Biol Chem 1981; 256(16)8256–8
  • Soprano D R., Smith J E., Goodman D S. Effect of retinol status on retinol-binding protein biosynthesis rate and translatable messenger RNA level in rat liver. J Biol Chem 1982; 257(13)7693–7
  • Smith J E., Muto Y, Milch P O., et al. The effects of chylomicron vitamin A on the metabolism of retinol-binding protein in the rat. J Biol Chem 1973; 248(5)1544–9
  • Muto Y, Smith J E., Milch P O., et al. Regulation of retinol-binding protein metabolism by vitamin A status in the rat. J Biol Chem 1972; 247(8)2542–50
  • Smith F R., Goodman D S. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 1971; 50(11)2426–36
  • Grippo J F., Sherman M I. Retinoid-binding proteins in embryonal carcinoma cells. Methods Enzymol 1990; 190: 148–55
  • Petkovich M, Brand N J., Krust A, et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–50
  • Giguere V, Ong E S., Segui P, et al. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624–9
  • Danielson M, Hinck L, Ringold G M. Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 1989; 57: 1131–8
  • Umesono K, Evans R M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989; 57: 1139–46
  • Brand N J., Petkovich M, Krust A, et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850–3
  • Benbrook D, Lernhardt E, Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669–72
  • Zelent A, Krust A, Petkovich M, et al. Cloning of murine α and ß retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 1989; 339: 714–21
  • Krust A, Kastner P, Petkovich M, et al. A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci USA 1989; 86: 5310–4
  • Mangelsdorf D J., Ong E S., Dyck A, et al. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–9
  • Evans R M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889–95
  • Glass C K., Devary O V., Rosenfeld M G. Multiple cell type-specific proteins differentially regulate target sequence recognition by the α retinoic acid receptor. Cell 1990; 63: 729–38
  • Yang N, Schule R, Mangelsdorf D J., et al. Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. Proc Natl Acad Sci USA 1991; 88: 3559–63
  • Ptashne M, Gann A AF. Activators and targets. Nature 1990; 346: 329–31
  • Lewin B. Commitment and activation at Pol II promoters: a tail of protein-protein interactions. Cell 1990; 61: 1161–4
  • Yu V C., Delsert C, Anderson B, et al. RXRß: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251–66
  • Mangelsdorf D J., Borgmeyer U, Heyman R A., et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329–44
  • Kliewer S A., Umesono K, Mangelsdorf D J., et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992; 355: 446–9
  • Leid M, Kastner P, Lyons R, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992; 68: 377–95
  • Zhang X, Hoffmann B, Tran P B-V, et al. Retinoid X receptors is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441–6
  • Bugge T H., Pohl J, Lonnoy O, et al. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 1992; 11: 1409–18
  • Marks M S., Hallenbeck P L., Nagata T, et al. H-2RIIBP (RXRß) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J 1992; 11: 1419–35
  • Glass C K., Devary O V., Rosenfeld M G. Multiple cell type-specific proteins differentially regulate target sequence recognition by the α retinoic acid receptor. Cell 1990; 63: 729–38
  • La Rosa G, Gudas L J. An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation. Proc Natl Acad Sci USA 1988; 85: 329–33
  • Vasios G W., Gold J D., Petkovich M, et al. A retinoic acid-responsive element is present in the 5′ flanking region of the laminin B 1 gene. Proc Natl Acad Sci USA 1989; 86: 9099–103
  • Duester G, Shean M L., McBride M S., et al. Retinoic acid response element in the human alcohol dehydrogenase gene ADH3: implications for regulation of retinoic acid synthesis. Mol Cell Biol 1991; 11: 1638–46
  • Lucas P C., O'Brien R M., Mitchell J A., et al. A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. Proc Natl Acad Sci USA 1991; 88: 2184–8
  • Hosler B A., LaRosa G J., Grippo J F., et al. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol Cell Biol 1989; 9: 5623–9
  • Felli M P., Vacca A, Meco D, et al. Retinoic acid induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 1991; 11: 4771–8
  • Reid L. From gradients to axes, from morphogenesis to differentiation. Cell 1990; 63: 875–82
  • Okamoto K, Okazawa H, Okuda A, et al. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990; 60: 461–72
  • Giguere V, Shago M, Zirngibl R, et al. Identification of a novel isoform of the retinoic acid receptor gamma expressed in the mouse embryo. Mol Cell Biol 1990; 10: 2335–40
  • Kastner P, Krust A, Mendelsohn C, et al. Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. Proc Natl Acad Sci USA 1990; 87: 2700–04
  • Leroy P, Krust A, Zelent A, et al. Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991; 10: 59–69
  • Zelent A, Mendelsohn C, Kastner P, et al. Differentially expressed isoforms of the mouse retinoic acid receptor ß are generated by usage of two promoters and alternative splicing. EMBO J 1991; 10: 71–81
  • Crettaz M, Baron A, Siegenthaler G, et al. Ligand specificities of recombinant retinoic acid receptors RARα and RARß. Biochem J 1990; 272: 391–7
  • Husmann M, Lehmann J, Hoffmann B, et al. Antagonism between retinoic acid receptors. Mol Cell Biol 1991; 11: 4097–103
  • Moore T. Effect of vitamin A deficiency in animals: pharmacology and toxicology of vitamin A. The vitamins2nd ed., W H. Sebrell, R S. Harris. Academic Press, New York 1967; 245–94
  • Peck G L. Retinoids in clinical dermatology. Progress in diseases of the skin, R Fleischmajer. Grune and Stratton, San Francisco 1981; 227–59
  • Bollag W. Retinoids and cancer. Cancer Chemother Pharmacol 1979; 3: 207–15
  • Harris C C., Kaufman D G., Sporn M B., et al. Histogenesis of squamous metaplasia and squamous cell carcinoma of the respiratory epithelium in an animal model. Cancer Chemother Rep (Part 3) 1973; 4(2)43–54
  • Nettesheim P, Snyder C, Kim J CS. Vitamin A and the susceptibility of respiratory tract tissues to carcinogenic insult. Environ Health Perspect 1979; 29: 89–93
  • Eccles S. Effects of retinoids on growth and dissemination of malignant tumours: immunological considerations. Biochem Pharmacol 1985; 34: 1599–610
  • Barker B M., Bender D A., Vitamin A. Vitamins in medicine. William Heinemann Medical Books Ltd, London 1980; Vol 2: 211–91
  • Durston A J., Timmermans J PM, Hage W J., et al. Retinoic acid causes an anterioposterior transformation in the developing central nervous system. Nature 1989; 340: 140–4
  • Maden M. Vitamin A and pattern formation in the regenerating limb. Nature 1982; 295: 672–5
  • Tickel C, Alberts B, Wolpert L, et al. Local application of retinoic acid to the limb bud mimics the action of the polarizing region. Nature 1982; 296: 564–5
  • Thaller C, Eichele G. Identification and spatial distribution of retinoids in the developing chick limb bud. Nature 1987; 327: 625–8
  • Thaller C, Eichele G. Isolation of 3,4-didehydroretinoic acid, a novel morphogenic signal in the chick wing bud. Nature 1990; 345: 815–9
  • Slack J MW. We have a morphogen. Nature 1987; 327: 553–4
  • Wanek N, Gardiner D M., Muneoka K, et al. Conversion by retinoic acid to anterior cells into ZPA cells in the chick wing bud. Nature 1991; 350: 81–3
  • Noji S, Nohno T, Koyama E, et al. Retinoic acid induces polarizing activity but is unlikely to be a morphogen in the chick limb bud. Nature 1991; 350: 83–6
  • Tabin C J. Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell 1991; 66: 199–217
  • Buck J, Ritter G, Dannecker L, et al. Retinol is essential for growth of activated human B cells. J Exp Med 1990; 171: 1613–24
  • Dennert G, Lotan R. Effects of retinoic acid on the immune system. Stimulation of the killer cell induction. Eur J Immunol 1978; 8(1)23–9
  • Seifter E, Rettura G, Levenson S M. Decreased resistance of C3H/HEHA mice to C3HBA tumour transplants: increased resistance due to supplemental vitamin A. J Natl Cancer Inst 1981; 67(2)467–72
  • Taub R N., Krantz A R., Dresser D W. The effect of localized injection of adjuvant material on the draining of lymph node. I. Histology. Immunology 1970; 18(2)171–86
  • Trechsel U, Evequoz V, Fleisch H. Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J 1985; 230: 339–44
  • Dennert G. Immunostimulation by retinoic acid. Retinoids, differentiation and disease, J Nugent, S Clark. Pitman, London 1985; 117–26
  • Sidell N, Famatiga E, Golub S H. Augmentation of human thymocyte proliferative responses by retinoic acid. Exp Cell Biol 1981; 49(5)239–45
  • Sidell N, Ramsdell F. Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 1988; 115: 299–309
  • Sidell N, Rieber P, Golub S H. Immunological aspects or retinoids in humans. I. Analysis of retinoic acid enhancement of thymocyte responses to PHA. Cell Immunol 1984; 87: 118–25
  • Prabhala R H., Garewal H S., Hicks M J., et al. The effects of 13-cis-retinoic acid and betacarotene on cellular immunity in humans. Cancer 1991; 67(6)1556–60
  • Prabhala R H. Two different molecular pathways of immunomodulation by retinoids and carotenoids. Diss Abst Int (B) 1990; 50(5)1775b
  • Jurin M, Tannock I F. Influence of vitamin A on immunological response. Immunology 1972; 23: 283–7
  • Athanassiades T J. Adjuvant treatment of vitamin A palmitate and analogues on cell-mediated immunity. J Natl Cancer Inst 1981; 67(5)1153–6
  • Spitznagel J K., Allison A C. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants. J Immunol 1970; 104(1)119–27
  • Dennert G. Retinoids and the immune system: immunostimulation by vitamin A. The retinoids, M B. Sporn, A B. Roberts, D S. Goodman. Academic Press. 1984; Vol 2: 373–90
  • Mori S. The changes in the para-ocular glands which follow the administration of diets low in fat-soluble A; with notes of the effect of the same diets on the salivary glands and the mucosa of the larynx and trachea. Bull Johns Hopkins Hosp 1922; 33: 357
  • Wolbach S B., Howe P R. Tissue changes following deprivation of fat-soluble vitamin A. J Exp Med 1925; 47: 743
  • Wolbach S B., Howe P R. Epithelial repair in recovery from vitamin A deficiency. J Exp Med 1933; 57: 511
  • Dowling J E., Wald G. The biological function of vitamin A acid. Proc Natl Acad Sci USA 1960; 46: 587
  • Ganguly J, Jayaram M. Possible systemic mode of action of vitamin A. Regulation of growth and differentiated function in eukaryote cells, G P. Talwar. Raven Press, New York 1975; 287
  • Boren H G., Pauley J, Wright E C., et al. Cell populations in the hamster tracheal epithelium in relation to vitamin A status. Int J Vitam Nutr Res 1974; 44: 382
  • Lasnitzki I. Hypovitaminosis-A in the mouse prostate gland cultured in chemically defined medium. Exp Cell Res 1962; 28: 40
  • Sporn M, Dunlop N, Newton D, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids). Fed Proc 1976; 35: 1332
  • Lotan R. Effects of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33
  • Lotan R. Effects of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605(1)33–91
  • Roberts A B., Sporn M B. Cellular biology and biochemistry of the retinoids. The retinoids, M B. Spom, A B. Roberts, D S. Goodman. Academic Press. 1984; Vol. 1: 209–86
  • Takigawa M, Ishida H, Takano T, et al. Polyamine and differentiation by parathyroid hormone is a good marker of differentiated chondrocytes. Proc Natl Acad Sci USA 1980; 77(3)1481–5
  • Logan, Takigawa M, Takano T, Suziki F. Restoration by cyclic AMP of the differentiated phenotype of chondrocytes from de-differentiated cells pretreated with retinoids. Mol Cell Biochem 1982; 42(3)145–53
  • , unpublished data
  • Lotan R, Nicholson G I. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumour cells in vitro. J Natl Cancer Inst 1977; 59: 1717–22
  • Thein R, Lotan R. Sensitivity of cultured human osteosarcoma and chondrosarcoma cells to retinoic acid. Cancer Res 1982; 42(11)4771–5
  • Marth C, Mayer I, Daxenbichler G. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem Pharmacol 1984; 33: 2217–21
  • Traganos F, Higgins P J., Bueti C, et al. Effects of retinoic acid versus dimethylsulfoxide on Friend erythroleukemia cell growth. II. Induction of quiescent nonproliferating cells. J Natl Cancer Inst 1984; 73: 205–18
  • Yen A, Reese S L., Albright K L. Control of cell differentiation during proliferation. II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changes. Leuk Res 1985; 9: 51–71
  • Craig R W., Frankfurt O S., Sakagami H, et al. Macromelecular and cell effects of different classes of agents inducing the maturation of human myeloblasts leukemia (ML-1) cells. Cancer Res 1984; 44: 2421–9
  • Vitale C, Rakowki I, Raza A. Number of DNA replication cycles completed by HL-60 cells during differentiation induced by 13-cis-retinoic acid (RA). Blood 1986; 68(suppl)194a, (Abstr.)
  • Green H. Terminal differentiation of cultured human epidermal cells. Cell 1977; 11(2)405–16
  • Breitman T R., Selonick S E., Collins S J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936–40
  • Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 333–43
  • Breitman T R., Collins S J., Keene B R. Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000
  • Clamon G H., Spom M B., Smith J M., et al. α and ß-retinyl acetate reverse metaplasia of vitamin A deficiency in hamster trachea in organ culture. Nature (London) 1974; 250: 64
  • Sporn M B., Clamon G H., Dunlop N M., et al. Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea. Nature (London) 1975; 253: 47
  • Clark J N., Marchok A C. The effect of vitamin A on cellular differentiation and mucous glycoprotein synthesis in long-term rat tracheal organ cultures. Differentiation 1979; 14: 175
  • Chopra D P. Squamous metaplasia in organ culture of vitamin A-deficient hamster trachea: cytokinetic and ultrastructural alterations. J Natl Cancer Inst 1982; 69: 895
  • Wong Y, Buck R. An electron microscopic study of metaplasia of the rat tracheal epithelium in vitamin A deficiency. Lab Invest 1971; 24: 55
  • Harris C C., Spom M B., Kaufman D G., et al. Histogenesis of squamous metaplasia in the hamster tracheal epithelium caused by vitamin A deficiency or benzo(a)pyrene-ferric oxide. J Natl Cancer Inst 1972; 48: 73
  • Port C D., Baxter D W., Harris C C. Surface morphology of tracheal epithelium in vitamin A deficiency and reversal. Experimental lung cancer carcinogenesis and bioassays, E Karbe, J F. Park. Springer-Verlag, Basel 1974; 257
  • Douer D, Koeffler H P. Retinoic acid: inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 1982; 69: 277–83
  • Collins S J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 1987; 70(5)1233–44
  • Jones-Villeneuve E MV, McBumey M, Rogers K A., et al. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Clin Biol 1982; 94: 253–62
  • McBurney M W., Jones-Villeneuve E MV, Edwards M, et al. Controlled differentiation of teratocarcinoma cells in culture. Nature 1982; 299: 165–7
  • Edwards M KS, McBurney M W. The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol 1983; 98: 187–91
  • Sato M, Hiragun A, Mitsui H. Preadipocytes possess cellular retinoid binding proteins and their differentiation is inhibited by retinoids. Biochem Biophys Res Commun 1980; 95(4)1839–45
  • Murray T, Russell T R. Inhibition of adipose conversion in 3T3-L2 cells by retinoic acid. J Supramol Struct 1980; 13(2)255–66
  • Hassell J R., Pennypacker J P., Lewis C A. Chondrogenesis and cell proliferation in limb bud cell cultures treated with cytosine arabinoside and vitamin A. Exp Cell Res 1978; 112(2)409–17
  • Pennypacker J P., Lewis C A., Hassell J R. Altered proteoglycan metabolism in mouse limb mesenchyme cell cultures treated with vitamin A. Arch Biochem Biophys 1978; 186(2)351–8
  • Hong W K., Lippman S M., Itri L M., et al. Prevention of second primary tumours with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323(12)795–801
  • Moon R C., Itri L M. Retinoids and cancer. The retinoids, M B. Spom, A B. Roberts, D S. Goodman. Academic Press. 1984; Vol. 2: 327–71
  • Cohen S M., Wittenberg J F., Bryan G T. Effects of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazoly]formamide. Cancer Res 1976; 36: 2334
  • Sporn M B., Squire R A., Brown C C., et al. 13-cis-retinoic acid inhibition of bladder carcinogenesis in the rat. Science 1977; 195: 487
  • Port C D., Sporn M, Kaufmann D G. Prevention of lung cancer in hamsters by 13-cis-retinoic acid. Proc Am Assoc Cancer Res 1975; 16: 21
  • Stinson S F., Reznik G, Donahoe R. Effect of three retinoids on tracheal carcinogenesis with N-methyl-N-nitrosurea in hamsters. J Natl Cancer Inst 1981; 66: 947–51
  • Grubbs C J., Becci P J., Moon R C. Characterization of 1-methyl-1-nitrosurea (MNU)-induced tracheal carcinogenesis and the effect of feeding the retinoid N-(4-hydroxyphenyl)retinamide. Proc Am Assoc Cancer Res 1980; 21: 102
  • Becci P J., Thompson H J., Grubbs C J., et al. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat. Cancer Res 1979; 39: 3141
  • Moon R C., Grubbs C J., Sporn M B., et al. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosurea. Nature 1977; 267: 620–21
  • Murray A E., Verma A K., Froscio M. Effect of carcinogenesis and tumour promoters on epidermal cyclic 3′:5′-monophosphate metabolism. Control mechanisms in cancer, W E. Criss, T Onto, J R. Sabine. Raven Press, New York 1976; 217
  • Berenblum I A. A speculative review: the possible nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res 1954; 14: 471
  • Berenblum I, Shubik P. The role of croton oil applications, associated with a single painting of a carcinogen, in tumour induction of the mouse's skin. Br J Cancer 1947; 1: 379
  • Van Duuren B L. Tumour promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res 1969; 11: 31
  • Diamond I, O'Brien T G., Baird W M. Tumour promoters and the mechanisms of tumour promotion. Adv Cancer Res 1980; 32: 1
  • Boutwell R K. The function and mechanism of promoters of carcinogenesis. Crit Rev Toxicol 1974; 2: 419
  • Boutwell R K. The biochemistry of preneoplasia in mouse skin. Cancer Res 1976; 36: 2631
  • Boutwell R K. The role of the induction of ornithine decarboxylase activity in tumour promotion. Origins of human cancer: proceedings of the cold spring harbor conference on cell proliferation, Book B, H H. Hiatt, J D. Watson, J A. Winsten. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1977; 773
  • O'Brien T G. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 1976; 36: 2644
  • O'Brien T G., Simsiman R C., Boutwell R K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumour promoting agents. Cancer Res 1975; 35: 1662
  • O'Brien T G., Simsiman R C., Boutwell R K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumour promotion. Cancer Res 1975; 35: 2426
  • Rozhin J, Wilson P S., Bull A W., et al. Ornithine decarboxylase activity in the rat and human colon. Cancer Res 1984; 44: 3226
  • Raina A, Janne J. Physiology of the natural polyamines putrescine, spermidine and spermine. Med Biol 1975; 53: 121
  • Liskamp R MJ, Brothman A R., Arcoleo J P., et al. Cellular uptake and localization of fluorescent derivatives of phorbol ester tumour promoters. Biochem Biophys Res Commun 1985; 131: 920
  • Ashendel C L. The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta 1985; 822: 219
  • Blumberg P M. Protein kinase C as the receptor for the phorbol ester tumour promoters: Sixth Rhoads memorial award lecture. Cancer Res 1988; 48: 1
  • Jetten A M., Shirley J E. Action of retinoic acid on the diacylglycerol-induced ornithine decarboxylase activity, reduction of EGF binding and protein kinase C activation in rat tracheal epithelial 2C5 cells. Exp Cell Res 1986; 166: 519
  • Loprinzi C L., Verma A K. Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity. Carcinogenesis 1985; 6: 1958
  • Kumar S, de Vellis J, Lowe N J., et al. trans-Retinoic acid inhibits the appearance of two phorbol ester-induced orntihine decarboxylase mRNAs in mouse epidermis. FEBS Lett 1987; 208: 151
  • Verma A K. Inhibition of phorbol ester-caused synthesis of mouse epidermal ornithine decarboxylase by retinoic acid. Biochim Biophys Acta 1985; 846: 109
  • Verma A J. Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumour promotion on the duration of retinoic acid treatment. Cancer Res 1987; 47: 5097
  • Shekelle R B., Lepper M, Liu S, et al. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 1981; 1185–9
  • Wald N, Idle M, Boreham J, et al. Low serum vitamin A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet 1980; 813–5
  • Kark J D., Smith A H., Switzer B R., et al. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst 1981; 66(1)7–16
  • Nomura A MY, Stemmermann G N., Heilbrun L K., et al. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 1985; 45: 2369–72
  • Byers T, Vena J, Mettlin C, et al. Dietary vitamin A and lung cancer risk: an analysis by histologic subtypes. Am J Epidemiol 1984; 120(5)759–76
  • Hinds M W., Kolonel L N., Hankin J H., et al. Dietary vitamin A, carotene, vitamin C and risk of lung cancer in Hawaii. Am J Epidemiol 1984; 119(2)227–37
  • Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer 1975; 15: 561–5
  • Pastorini U. Lung cancer chemoprevention: facts and hopes. Lung Cancer 1991; 7: 133–50
  • Sestilli M A. Chemoprevention clinical trial. Problems and solutions. NIH Publication. 1985, No. 85–2715
  • Greenwald P, Sondik E, Lynch B S. Diet and chemoprevention in NCI's research strategy to achieve national cancer control objectives. Annu Rev Public Health 1986; 7: 267–91
  • Mathe G J., Gouveia J, Hercend T, et al. Correlation between precancerous bronchial metaplasia and cigarette consumption, the preliminary results of retinoid treatment. Cancer Detect Prev 1982; 5: 461–6
  • Saffiotti U, Montesano R, Sellakumar A R., et al. Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumours. Cancer 1967; 20: 857–64
  • Hubert D D., Holiat S M., Smith W E., et al. Inhibition of transplanted carcinomas to mice by retinoids but not by vitamin C. Cancer Treat Rep 1983; 67: 1061–6
  • Lippman S M., Kessler J F., Meyskens F L. Retinoids as preventative and therapeutic anticancer agents (part II). Cancer Treat Rep 1987; 71: 493–515
  • Micksche M, Cerm C, Kokern O, et al. Stimulation of immune response in lung cancer patients by vitamin A therapy. Oncology 1977; 34: 234–8
  • Saccomanno G, Moran P G., Schmidt R D. Effects of 13-cis retinoids on pre-malignant and malignant cells of lung origin. Acta Cytol (Baltimore) 1982; 26: 78–85
  • Weber W, Arnold H, Drings P, et al. Etretinate (RO-10–9359, Tigason), CCNU (1-(2-chloroethyl)-3-cyclohexyl-1 -nitrosurea) and bleomycin vs. CCNU and bleomycin in advanced squamous cell carcinoma of the lung. Onkologie 1982; 6: 62–5
  • Greenspan J S., Goldhaber P. Oral manifestations of disease. Harrison's principles of internal medicine12th Ed., J D. Wilson, E Braunwald, K J. Isselbacher, et al. McGraw-Hill. 1991; 242–9
  • Koch H F. Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. J Maxillofac Surg 1978; 6: 59–63
  • Koch H F. Effect of retinoids on precancerous lesions of oral mucosa. Retinoids, advances in basic research and therapy, C E. Orfanos, et al. Springer-Verlag, Berlin 1981; 307–12
  • Hong W K., Endicott J, Itri L M., et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–5
  • Lippman S M., Toth B B., Batsakis J G., et al. Low dose 13-cis-retinoic acid (13cRA) maintains remission in oral premalignancy: more effective than ß-carotene in randomized trial. Proceedings of ASCO 1990; 9: 59, (Abstr. 225)
  • Lippman S, Kessler J, Al-Sarraf M, et al. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs 1988; 6: 51–6
  • Peck G L., Olsen T G., Yoder F W., et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Eng J Med 1979; 300(7)329–33
  • Ehmann C W., Voorhees J J. International studies of the efficacy of etretinate in the treatment of psoriasis. J Am Acad Dermatol 1982; 6(4 pt 2 Suppl)692–6
  • Peck G L., Yoder F W. Treatment of lamellar ichthyosis and other keratinising dermatoses with an oral synthetic retinoid. Lancet 1976; 2(7996)117–4
  • Melanoma and skin cancer: proceedings of international cancer conference, McCarthy. McGraw-Hill, Sydney 1972; 349–65
  • Bollag W, Ott F. Vitamin A in benign and malignant epithelial tumours of the skin. Acta Dermatol Venereol 1975, Suppl 74: 163–6
  • Grupper C H., Berretti B. Cutaneous neoplasia and etretinate. Proceedings of the 13th international congress of chemotherapy, K H. Spitzky, K Karrer. Egermann, Vienna 1983; 24–27
  • Swanson N A. Skin cancer. Harrison's principles of internal medicine12th Ed., J D. Wilson, E Braunwald, K J. Isselbacher, et al. McGraw-Hill. 1991; 1633–4
  • Berretti B, Grouper C H., Edelson Y, et al. Aromatic retinoid in the treatment of multiple superficial basal cell carcinoma, arsenic keratoses and keratoacanthoma. Retinoids, advances in basic research and therapy, C E. Ofanos. Springer-Verlag, Berlin 1981; 397–9
  • Peck G L. Chemoprevention and treatment of skin cancer with retinoids. Cancer Surv 1983; 2: 315–26
  • Peck G L. Therapy and prevention of skin cancer. Retinoids: new trends in research and therapy, J H. Saurat. Karger, Basel 1985; 345–54
  • Peck G L., Olsen T G., Butkus D, et al. Treatment of basal cell carcinomas with 13-cis-retinoic acid. Proc Am Assoc Cancer Res 1979; 20: 56
  • Lippman S, Meyskens F. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 1987; 107: 499–502
  • Kingston T, Gaskell S, Marks R. The effects of a novel potent oral retinoid (R013–6298) in the treatment of multiple solar keratoses and squamous cell epithelioma. Eur J Cancer 1983; 19: 1201–05
  • Lottan R, Lotan D. Inhibition of melanoma cell growth by retinoids. Structure-activity relationship. Chemistry and biology of synthetic retinoids, M I. Dawson, W H. Okamura. CRC Press. 1990; 251–73
  • Levine N, Meyskens F L., Jr. Topical vitamin-A-acid therapy for cutaneous metastatic melanoma. Lancet 1980; 2: 224–6
  • Cassidy J, Lippman M, Lacroix A, et al. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer and other malignancies. Proc Am Soc Clin Oncol 1981; 22: 441
  • Rustin G JS, Bagshawe K D. Trial of an aromatic retinoid in patients with solid tumours. Br J Cancer 1982; 45: 304–08
  • Meyskens F L., Gilmartin E, Alberts D S., et al. Activity of isotretinoin against squamous cell cancers and neoplastic lesions. Cancer Treat Rep 1982; 66: 1315–9
  • Lippman S, Parkinson D, Itri L, et al. 13-cis-Retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235–41
  • Borrow J, Goddard A D., Sheer D, et al. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–80
  • Alcalay M, Zangrilli D, Pandolfi P P., et al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor ot locus. Proc Natl Acad Sci USA 1991; 88: 1977–81
  • Kakizuka A, Miller W H., Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARot with a novel putative transcription factor, PML. Cell 1991; 66: 663–74
  • De The H, Lavau C, Marchio A, et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–84
  • Pendergast A M., Muller A J., Havlik M H., et al. BCR sequences essential for transformation by BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependant manner. Cell 1991; 66: 161–71
  • Huang M, Ye Y, Chen S, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
  • Castaigne S, Chomienne C, Daniel M, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–09
  • Chomienne C, Ballerini N, Balitrand N, et al. Retinoic acid therapy for promyelocytic leukemia. Lancet 1989; 2: 746–7
  • Warrell R, Frankel S, Miller W, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N EnglJ Med 1991; 324: 1385–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.